share_log

Jefferies Downgrades MEI Pharma to Underperform, Lowers Price Target to $0.1

Jefferies Downgrades MEI Pharma to Underperform, Lowers Price Target to $0.1

杰富瑞将MEI Pharma的评级下调至表现不佳,将目标股价下调至0.1美元
Benzinga Real-time News ·  2023/02/08 05:18

Jefferies analyst Chris Howerton downgrades MEI Pharma (NASDAQ:MEIP) from Hold to Underperform and lowers the price target from $0.4 to $0.1.

杰富瑞分析师Chris Howerton将美药(纳斯达克股票代码:MEIP)的评级从持有下调至表现不佳,并将目标价从0.4美元下调至0.1美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发